Steering Chimeric Antigen Receptor T Cells Into the Hodgkin Lymphoma Niche.


Journal article


Paul J. Bröckelmann, Sven Borchmann, Peter Borchmann, Andreas Engert
Journal of Clinical Oncology, 2020 Aug 18

Cite

Cite

APA   Click to copy
Bröckelmann, P. J., Borchmann, S., Borchmann, P., & Engert, A. (2020). Steering Chimeric Antigen Receptor T Cells Into the Hodgkin Lymphoma Niche. Journal of Clinical Oncology.


Chicago/Turabian   Click to copy
Bröckelmann, Paul J., Sven Borchmann, Peter Borchmann, and Andreas Engert. “Steering Chimeric Antigen Receptor T Cells Into the Hodgkin Lymphoma Niche.” Journal of Clinical Oncology (August 18, 2020).


MLA   Click to copy
Bröckelmann, Paul J., et al. “Steering Chimeric Antigen Receptor T Cells Into the Hodgkin Lymphoma Niche.” Journal of Clinical Oncology, Aug. 2020.


BibTeX   Click to copy

@article{paul2020a,
  title = {Steering Chimeric Antigen Receptor T Cells Into the Hodgkin Lymphoma Niche.},
  year = {2020},
  month = aug,
  day = {18},
  journal = {Journal of Clinical Oncology},
  author = {Bröckelmann, Paul J. and Borchmann, Sven and Borchmann, Peter and Engert, Andreas},
  month_numeric = {8}
}


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in